Genetic modification of stem cells for improved therapy of the infarcted myocardium

Husnain Kh Haider, Anique Mustafa, Yuliang Feng, Muhammad Ashraf

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The conventional treatment modalities for ischemic heart disease only provide symptomatic relief to the patient without repairing and regenerating the damaged myocardium. Stem cell transplantation has emerged as a promising alternative therapeutic approach for cardiovascular diseases. Stem cells possess the potential of differentiation to adopt morphofunctional cardiac and vasculogenic phenotypes to repopulate the scar tissue and restore regional blood flow in the ischemic myocardium. These beneficial therapeutic effects make stem cell transplantation the method of choice for the treatment of ischemic heart disease. The efficacy of stem cell transplantation may be augmented by genetic manipulation of the cells prior to transplantation. Not only will insertion of therapeutic transgene(s) into the stem cells support the survival and differentiation of cells in the unfavorable microenvironment of the ischemic myocardium, but also the genetically manipulated stem cells will serve as a source of the transgene expression product in the heart for therapeutic benefits. We provide an overview of the extensively studied stem cell types for cardiac regeneration, the various methods in which these cells have been genetically manipulated and rationale of genetic modification of stem cells for use in regenerative cardiovascular therapeutics.

Original languageEnglish (US)
Pages (from-to)1446-1457
Number of pages12
JournalMolecular Pharmaceutics
Volume8
Issue number5
DOIs
StatePublished - Oct 3 2011
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Myocardium
Stem Cells
Stem Cell Transplantation
Transgenes
Myocardial Ischemia
Therapeutics
Regional Blood Flow
Therapeutic Uses
Cicatrix
Regeneration
Cell Differentiation
Cell Survival
Cardiovascular Diseases
Transplantation
Phenotype

Keywords

  • angiomyogenesis
  • gene therapy
  • heart
  • stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Genetic modification of stem cells for improved therapy of the infarcted myocardium. / Haider, Husnain Kh; Mustafa, Anique; Feng, Yuliang; Ashraf, Muhammad.

In: Molecular Pharmaceutics, Vol. 8, No. 5, 03.10.2011, p. 1446-1457.

Research output: Contribution to journalReview article

Haider, Husnain Kh ; Mustafa, Anique ; Feng, Yuliang ; Ashraf, Muhammad. / Genetic modification of stem cells for improved therapy of the infarcted myocardium. In: Molecular Pharmaceutics. 2011 ; Vol. 8, No. 5. pp. 1446-1457.
@article{6b0cd875a13a4c0291ecae88a53bbc33,
title = "Genetic modification of stem cells for improved therapy of the infarcted myocardium",
abstract = "The conventional treatment modalities for ischemic heart disease only provide symptomatic relief to the patient without repairing and regenerating the damaged myocardium. Stem cell transplantation has emerged as a promising alternative therapeutic approach for cardiovascular diseases. Stem cells possess the potential of differentiation to adopt morphofunctional cardiac and vasculogenic phenotypes to repopulate the scar tissue and restore regional blood flow in the ischemic myocardium. These beneficial therapeutic effects make stem cell transplantation the method of choice for the treatment of ischemic heart disease. The efficacy of stem cell transplantation may be augmented by genetic manipulation of the cells prior to transplantation. Not only will insertion of therapeutic transgene(s) into the stem cells support the survival and differentiation of cells in the unfavorable microenvironment of the ischemic myocardium, but also the genetically manipulated stem cells will serve as a source of the transgene expression product in the heart for therapeutic benefits. We provide an overview of the extensively studied stem cell types for cardiac regeneration, the various methods in which these cells have been genetically manipulated and rationale of genetic modification of stem cells for use in regenerative cardiovascular therapeutics.",
keywords = "angiomyogenesis, gene therapy, heart, stem cells",
author = "Haider, {Husnain Kh} and Anique Mustafa and Yuliang Feng and Muhammad Ashraf",
year = "2011",
month = "10",
day = "3",
doi = "10.1021/mp2001318",
language = "English (US)",
volume = "8",
pages = "1446--1457",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Genetic modification of stem cells for improved therapy of the infarcted myocardium

AU - Haider, Husnain Kh

AU - Mustafa, Anique

AU - Feng, Yuliang

AU - Ashraf, Muhammad

PY - 2011/10/3

Y1 - 2011/10/3

N2 - The conventional treatment modalities for ischemic heart disease only provide symptomatic relief to the patient without repairing and regenerating the damaged myocardium. Stem cell transplantation has emerged as a promising alternative therapeutic approach for cardiovascular diseases. Stem cells possess the potential of differentiation to adopt morphofunctional cardiac and vasculogenic phenotypes to repopulate the scar tissue and restore regional blood flow in the ischemic myocardium. These beneficial therapeutic effects make stem cell transplantation the method of choice for the treatment of ischemic heart disease. The efficacy of stem cell transplantation may be augmented by genetic manipulation of the cells prior to transplantation. Not only will insertion of therapeutic transgene(s) into the stem cells support the survival and differentiation of cells in the unfavorable microenvironment of the ischemic myocardium, but also the genetically manipulated stem cells will serve as a source of the transgene expression product in the heart for therapeutic benefits. We provide an overview of the extensively studied stem cell types for cardiac regeneration, the various methods in which these cells have been genetically manipulated and rationale of genetic modification of stem cells for use in regenerative cardiovascular therapeutics.

AB - The conventional treatment modalities for ischemic heart disease only provide symptomatic relief to the patient without repairing and regenerating the damaged myocardium. Stem cell transplantation has emerged as a promising alternative therapeutic approach for cardiovascular diseases. Stem cells possess the potential of differentiation to adopt morphofunctional cardiac and vasculogenic phenotypes to repopulate the scar tissue and restore regional blood flow in the ischemic myocardium. These beneficial therapeutic effects make stem cell transplantation the method of choice for the treatment of ischemic heart disease. The efficacy of stem cell transplantation may be augmented by genetic manipulation of the cells prior to transplantation. Not only will insertion of therapeutic transgene(s) into the stem cells support the survival and differentiation of cells in the unfavorable microenvironment of the ischemic myocardium, but also the genetically manipulated stem cells will serve as a source of the transgene expression product in the heart for therapeutic benefits. We provide an overview of the extensively studied stem cell types for cardiac regeneration, the various methods in which these cells have been genetically manipulated and rationale of genetic modification of stem cells for use in regenerative cardiovascular therapeutics.

KW - angiomyogenesis

KW - gene therapy

KW - heart

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=80053475375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053475375&partnerID=8YFLogxK

U2 - 10.1021/mp2001318

DO - 10.1021/mp2001318

M3 - Review article

C2 - 21591779

AN - SCOPUS:80053475375

VL - 8

SP - 1446

EP - 1457

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 5

ER -